Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Synthetic Biologics (SYN) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.70

up-down-arrow $-0.02 (-2.78%)

As on 05-Dec-2022 09:30EDT

Market cap

info icon

$16 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- -- -29.88 2.56 8.85
Net Profit 2.31 -48.27 -39.15 -9.34 1.33
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info ----------
Net Margin info -14,116.21-7,173.89-----22,825.00
Return on equity info -66.18-317.28-30.68-38.85-89.69
Return on Capital info -63.94-315.94---37.82-85.14
Return on Assets info -59.72-61.43-22.75-36.22-78.32
Debt to Equity (x) info ----0.000.020.06

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
--
-37.82
-85.14
-68.85
-95.93
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-30.68

Higher than Peers by 9.72

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
-30.68
-38.85
-89.69
-69.99
-95.93
Peer Median
-40.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-22.75

Higher than Peers by 8.23

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
-22.75
-36.22
-78.32
-64.60
-54.58
Peer Median
-30.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
--
--
-22,825.00
-5,407.42
-322.10
Peer Median
-92.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-29.88

Lower than Peers by 29.08

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
-29.88
-40.49
35.13
10.86
33.07
Peer Median
-0.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-39.15

Lower than Peers by 31.85

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
-39.15
-42.06
34.37
-14.48
11.91
Peer Median
-7.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.00

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
0.00
0.02
0.06
0.05
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
--
0.00
0.04
0.02
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

4.00

Lower than Peers by 1.81

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
4.00
19.37
2.67
3.11
8.72
Peer Median
5.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

4.00

Lower than Peers by 1.70

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
4.00
--
--
--
--
Peer Median
5.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-644.23

Lower than Peers by 642.15

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
-644.23
-2,379.00
--
--
--
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
--
--
--
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Book Value

0.24

Lower than Peers by 4.94

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
0.24
--
--
--
--
Peer Median
5.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

2.01

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
2.01
4.64
0.58
0.93
1.67
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

16

Lower than Peers by 130

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Synthetic Biologics (SYN)
16
--
--
--
--
Peer Median
146
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...